Angiogenic peptide nanofibers repair cardiac tissue defect after myocardial infarction

Myocardial infarction remains one of the top leading causes of death in the world and the damage sustained in the heart eventually develops into heart failure. Limited conventional treatment options due to the inability of the myocardium to regenerate after injury and shortage of organ donors require the development of alternative therapies to repair the damaged myocardium. Current efforts in repairing damage after myocardial infarction concentrates on using biologically derived molecules such as growth factors or stem cells, which carry risks of serious side effects including the formation of teratomas. Here, we demonstrate that synthetic glycosaminoglycan (GAG) mimetic peptide nanofiber scaffolds induce neovascularization in cardiovascular tissue after myocardial infarction, without the addition of any biologically derived factors or stem cells. When the GAG mimetic nanofiber gels were injected in the infarct site of rodent myocardial infarct model, increased VEGF-A expression and recruitment of vascular cells was observed. This was accompanied with significant degree of neovascularization and better cardiac performance when compared to the control saline group. The results demonstrate the potential of future clinical applications of these bioactive peptide nanofibers as a promising strategy for cardiovascular repair. Statement of Significance We present a synthetic bioactive peptide nanofiber system can enhance cardiac function and enhance cardiovascular regeneration after myocardial infarction (MI) without the addition of growth factors, stem cells or other biologically derived molecules. Current state of the art in cardiac repair after MI utilize at least one of the above mentioned biologically derived molecules, thus our approach is ground-breaking for cardiovascular therapy after MI. In this work, we showed that synthetic glycosaminoglycan (GAG) mimetic peptide nanofiber scaffolds induce neovascularization and cardiomyocyte differentiation for the regeneration of cardiovascular tissue after myocardial infarction in a rat infarct model. When the peptide nanofiber gels were injected in infarct site at rodent myocardial infarct model, recruitment of vascular cells was observed, neovascularization was significantly induced and cardiac performance was improved. These results demonstrate the potential of future clinical applications of these bioactive peptide nanofibers as a promising strategy for cardiovascular repair. © 2017 Acta Materialia Inc

Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals

10.1016/j.biomaterials.2007.10.051Biomaterials297937-943BIMA

Human embryonic stem cell (hES) colonies display a higher degree of spontaneous differentiation when passaged at lower densities

10.1290/0510071.1In Vitro Cellular and Developmental Biology - Animal423-454-57ICDB

Directing endothelial differentiation of human embryonic stem cells via transduction with an adenoviral vector expressing the VEGF165gene

10.1002/jgm.1034Journal of Gene Medicine96452-46

Biocompatibility study of PEI-NaYF4: Yb,Er upconversion nanoparticles

10.1007/978-3-540-69139-6-25IFMBE Proceedings21 IFMBE182-8

Efficient differentiation of human embryonic stem cells to arterial and venous endothelial cells under feeder- and serum-free conditions

10.1186/s13287-015-0260-5Stem Cell Research and Therapy6126

Utilizing stem cells for myocardial repair - To differentiate or not to differentiate prior to transplantation?

10.1080/14017430510009023Scandinavian Cardiovascular Journal393131-134SCJO

Dual delivery of VEGF and ANG-1 in ischemic hearts using an injectable hydrogel

10.1016/j.actbio.2016.10.013Acta Biomaterialia4858-6

Angiomyogenesis using human myoblast carrying human VEGF165 for injured heart.

Annals of the Academy of Medicine, Singapore325 SupplS21-2